Vaccine News: FDA Filings, Trials, Global Updates and more

Moderna submitted its updated Spikevax COVID-19 vaccine targeting LP.8.1 to the FDA, while Pfizer and BioNTech filed a similar vaccine with the EMA. Vaxart began dosing 10,000 participants in a pivotal trial of its oral COVID-19 pill, supported by major U.S. funding. FDA expanded MenQuadfi use to infants. Evaxion reported strong Phase 2 results for its personalized cancer vaccine. Moderna announced promising data for its H5 avian flu shot. SK Bioscience completed a key manufacturing site for its 21-valent pneumococcal vaccine.

Видео Vaccine News: FDA Filings, Trials, Global Updates and more канала LucidQuest